From Genome Analysis Wiki
Jump to navigationJump to search
1,486 bytes added
, 22:10, 29 September 2011
Line 33: |
Line 33: |
| * Shaun Purcell (Mount Sinai School of Medicine / Broad Institute) | | * Shaun Purcell (Mount Sinai School of Medicine / Broad Institute) |
| * Josh Smith (University of Washington) | | * Josh Smith (University of Washington) |
| + | |
| + | == Content Contributors == |
| + | |
| + | |
| + | {| class="sortable wikitable" |
| + | |- |
| + | |'''Contributor''' |
| + | |'''Enrichment''' |
| + | |'''Major Ethnicity''' |
| + | |'''N''' |
| + | |'''Contact''' |
| + | |- |
| + | |NHLBI Exome Sequencing Project (5 tranches) |
| + | |Cardiovascular, Lung Traits, obesity |
| + | |European, African American |
| + | |4260 |
| + | |D. Nickerson, D. Altshuler and S. Rich |
| + | |- |
| + | |Autism (2 tranches) |
| + | |Autism |
| + | |European |
| + | |1778 |
| + | |M. Daly and R. Gibbs |
| + | |- |
| + | |GO T2D (2 tranches) |
| + | |Type 2 diabetes |
| + | |European |
| + | |1618 |
| + | |D. Altshuler, M. Boehnke, M. McCarthy |
| + | |- |
| + | |1000 Genomes Project (2 tranches) |
| + | |Random Sample |
| + | |Diverse |
| + | |1128 |
| + | |H. M. Kang |
| + | |- |
| + | |Sweden Schizophrenia Study |
| + | |Schizophrenia |
| + | |European |
| + | |525 |
| + | |S. Purcell and P. Sklar |
| + | |- |
| + | |SardiNIA |
| + | |Random Sample |
| + | |European |
| + | |508 |
| + | |F. Cucca and G. Abecasis |
| + | |- |
| + | |Sanger / CoLaus |
| + | |Overweight, Diabetes, Fasting Glucose |
| + | |European |
| + | |456 |
| + | |I. Barroso |
| + | |- |
| + | |Cancer Genome Atlas |
| + | |Cancer |
| + | |European |
| + | |422 |
| + | |S. Gabriel |
| + | |- |
| + | |T2D Genes |
| + | |Type 2 diabetes |
| + | |Hispanic |
| + | |362 |
| + | |J. Blangero and G. Abecasis |
| + | |- |
| + | |Cancer Cohort Study |
| + | |Cancer |
| + | |Chinese |
| + | |327 |
| + | |W. Zheng |
| + | |- |
| + | |BMI Extremes |
| + | |BMI |
| + | |European |
| + | |46 |
| + | |J. Hirschhorn |
| + | |- |
| + | |I2B2 - Major Depression |
| + | |Major Depression, Major Depressive Disorder |
| + | |European |
| + | |50 |
| + | |R. Perlis and J. Smoller |
| + | |- |
| + | |SAEC DILI (merged w/Autism tranches) |
| + | |Augmentin DILI |
| + | |European |
| + | |117 |
| + | |M. Daly and A. Holden |
| + | |- |
| + | |Int’l HIV Controllers Study |
| + | |HIV Controllers |
| + | |European |
| + | |121 |
| + | |P. De Bakker |
| + | |- |
| + | |Lipid Extremes |
| + | |Lipid Extremes |
| + | |European |
| + | |131 |
| + | |S. Kathiresan and D. Rader |
| + | |- |
| + | |Pfizer – MGH – Broad |
| + | |T2D extremes of risk |
| + | |European |
| + | |182 |
| + | |D. Altshuler |
| + | |} |
| | | |
| = Chip Goals = | | = Chip Goals = |